Swati Gupta1, Sarman Singh. 1. Division of Clinical Microbiology, Department of Laboratory Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
Abstract
AIM: To determine the prevalence of hepatitis B and C virus infections in human immunodeficiency virus (HIV) -positive patients at a tertiary care hospital in New Delhi, India. METHODS: Serum samples from 451 HIV positive patients were analyzed for HBsAg and HCV antibodies during three years (Jan 2003-Dec 2005). The control group comprised of apparently healthy bone-marrow and renal donors. RESULTS: The study population comprised essentially of heterosexually transmitted HIV infection. The prevalence rate of HBsAg in this population was 5.3% as compared to 1.4% in apparently healthy donors (P < 0.001). Though prevalence of HCV co-infection (2.43%) was lower than HBV in this group of HIV positive patients, the prevalence was significantly higher (P < 0.05) than controls (0.7%). Triple infection of HIV, HBV and HCV was not detected in any patient. CONCLUSION: Our study shows a significantly high prevalence of hepatitis virus infections in HIV infected patients. Hepatitis viruses in HIV may lead to faster progression to liver cirrhosis and a higher risk of antiretroviral therapy induced hepatotoxicity. Therefore, it would be advisable to detect hepatitis virus co-infections in these patients at the earliest.
AIM: To determine the prevalence of hepatitis B and C virus infections in human immunodeficiency virus (HIV) -positive patients at a tertiary care hospital in New Delhi, India. METHODS: Serum samples from 451 HIV positive patients were analyzed for HBsAg and HCV antibodies during three years (Jan 2003-Dec 2005). The control group comprised of apparently healthy bone-marrow and renal donors. RESULTS: The study population comprised essentially of heterosexually transmitted HIV infection. The prevalence rate of HBsAg in this population was 5.3% as compared to 1.4% in apparently healthy donors (P < 0.001). Though prevalence of HCV co-infection (2.43%) was lower than HBV in this group of HIV positive patients, the prevalence was significantly higher (P < 0.05) than controls (0.7%). Triple infection of HIV, HBV and HCV was not detected in any patient. CONCLUSION: Our study shows a significantly high prevalence of hepatitis virus infections in HIV infectedpatients. Hepatitis viruses in HIV may lead to faster progression to liver cirrhosis and a higher risk of antiretroviral therapy induced hepatotoxicity. Therefore, it would be advisable to detect hepatitis virus co-infections in these patients at the earliest.
Authors: N Kumarasamy; Snigdha Vallabhaneni; Timothy P Flanigan; Kenneth H Mayer; Suniti Solomon Journal: Indian J Med Res Date: 2005-04 Impact factor: 2.375
Authors: M K Saha; S Chakrabarti; S Panda; T N Naik; B Manna; A Chatterjee; R Detels; S K Bhattacharya Journal: Indian J Med Res Date: 2000-02 Impact factor: 2.375
Authors: Ponsiano Ocama; Michael Katwere; Theresa Piloya; Jordan Feld; Kenneth C Opio; Andrew Kambugu; Elly Katabira; David Thomas; Robert Colebunders; Allan Ronald Journal: Afr Health Sci Date: 2008-03 Impact factor: 0.927
Authors: Shanmugam Saravanan; Vidya Madhavan; Vijayakumar Velu; Kailapuri G Murugavel; Greer Waldrop; Sunil S Solomon; Pachamuthu Balakrishnan; Nagalingeswaran Kumarasamy; Davey M Smith; Kenneth H Mayer; Suniti Solomon; Sadras P Thyagarajan Journal: J Int Assoc Provid AIDS Care Date: 2013-05-30